Drug Search Results
More Filters [+]

Clotiapine

Alternative Names: clotiapine
Latest Update: 2024-08-27
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: DR Antagonist,5-HT Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Belgium | Israel | South Africa | Spain | Switzerland | Taiwan | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: Fundacion Progreso y Salud
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Clotiapine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Schizophrenia

Phase 3: Schizophrenia|Psychotic Disorders

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

INTENSIFY SZ

P4

Unknown Status

Schizophrenia

2026-06-30

Discontinuation clinical trial in first episode of non-affective psychosis

P3

Terminated

Schizophrenia

2016-03-21

NONSTOP

P3

Unknown status

Psychotic Disorders|Schizophrenia

2015-11-01

Recent News Events